Document is current
Any future updates will be listed below
-
Authors
Wu, Zhenghao
Zheng, Peng
Qi, Ruobing
Xiao, Yunxiao
Xi, Zihan
Dai, Lei
Chen, Tao
Wang, Qianheng
Zhang, Furong
Wang, Rong
Tang, Zimei
Zhao, Xiangwang
Tan, Jie
Ming, Jie
Lei, Ping
Liu, Chunping
Huang, Tao
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82303179, 82400428, 82002834, 82270830, 81871307, 82373144)
Natural Science Foundation of Hubei Province (2024AFB626, 2024AFB062)
Hubei Province Postdoctoral Innovation Practice Program (2023-36)
Westlake Omics Junior Clinician Support Program (2021)
State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases (2024; no.17)
Hubei Provincial Department of Science and Technology Key Innovation Program (2021BCA142)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 15 July 2025
First Online: 24 July 2025
Declarations
:
: Blood from healthy donors were obtained from the Wuhan Union Hospital with IRB approval by the Ethical Committee of the Tongji Medical College of Huazhong University of Science and Technology. Informed written consent from all participants or next of kin was obtained prior to the research.
: The authors understand Journal of Experimental & Clinical Cancer Research is an open access journal that levies an article processing charge per articles accepted for publication. By submitting my article the authors agree to pay this charge in full if my article is accepted for publication. The results/data/figures in this manuscript have not been published elsewhere, nor are they under consideration (from you or one of your Contributing Authors) by another publisher. The authors have read the Nature Portfolio journal policies on author responsibilities and submit this manuscript in accordance with those policies.
: The authors declare no competing interests.
